ACCULYSE Trademark

Trademark Overview

On Monday, October 2, 2023, a trademark application was filed for ACCULYSE with the United States Patent and Trademark Office. The USPTO has given the ACCULYSE trademark a serial number of 98205862. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, June 9, 2025. This trademark is owned by Syncromune, Inc.. The ACCULYSE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body causing tumor cell lysis; Medical apparatus, namely, infusion and injection devices for locally targeted drug administration
acculyse

General Information

Serial Number98205862
Word MarkACCULYSE
Filing DateMonday, October 2, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, June 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements

Goods and ServicesMedical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body causing tumor cell lysis; Medical apparatus, namely, infusion and injection devices for locally targeted drug administration

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSyncromune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33308
Party NameSyncromune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33308

Trademark Events

Event DateEvent Description
Saturday, December 23, 2023NON-FINAL ACTION WRITTEN
Thursday, October 5, 2023NEW APPLICATION ENTERED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 23, 2023ASSIGNED TO EXAMINER
Saturday, December 23, 2023NON-FINAL ACTION E-MAILED
Saturday, December 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 12, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 12, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, March 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 12, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, March 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, December 6, 2024SOU EXTENSION 1 FILED
Friday, December 6, 2024SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 9, 2025SOU EXTENSION 2 FILED
Monday, June 9, 2025SOU TEAS EXTENSION RECEIVED
Monday, June 9, 2025SOU EXTENSION 2 GRANTED

Related Keywords

acculyse tumor medical devices namely apparatus lysis cell infusion locally administration